Galafold 123 MG
Ended Awarded
- Contract number
- 36C24526N0881
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,840
Award facts
- Contract value 100% obligated
- $22,839.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 5, operating under the Department of Veterans Affairs, issued a $22,839.61 delivery order to Amicus Therapeutics US, LLC on September 29, 2026, for Galafold 123 mg capsules under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The parent vehicle is the GSA Pharmaceuticals and Drugs multiple-award schedule contract (FSS-61-IB), a federal supply schedule for pharmaceutical products serving VA networks. Place of performance is Philadelphia, PA. The order is firm fixed price with an ultimate completion date of October 2, 2026, and carries no set-aside designation. Amicus Therapeutics US, LLC supplies Galafold (migalastat) 123 mg capsules, an FDA-approved enzyme replacement therapy for Fabry disease treatment, directly as prime with no subcontractor involvement.
Quick answers
Who was awarded contract 36C24526N0881?
36C24526N0881 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 29, 2026.
How much is contract 36C24526N0881 worth?
The government has obligated $22,840 on 36C24526N0881.
Is contract 36C24526N0881 an order under another contract?
Yes. 36C24526N0881 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0881 competed?
The extent of competition for 36C24526N0881 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award